These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 37725119)

  • 1. MK-801 and cognitive functions: Investigating the behavioral effects of a non-competitive NMDA receptor antagonist.
    Janus A; Lustyk K; Pytka K
    Psychopharmacology (Berl); 2023 Dec; 240(12):2435-2457. PubMed ID: 37725119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice.
    Wu J; Zou H; Strong JA; Yu J; Zhou X; Xie Q; Zhao G; Jin M; Yu L
    Psychopharmacology (Berl); 2005 Jan; 177(3):256-63. PubMed ID: 15290006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine.
    Ito K; Abekawa T; Koyama T
    Psychopharmacology (Berl); 2006 Jul; 186(4):525-33. PubMed ID: 16758239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
    Irifune M; Shimizu T; Nomoto M; Fukuda T
    Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
    Wedzony K; Czyrak A; Maćkowiak M; Fijał K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
    Dall'Igna OP; Da Silva AL; Dietrich MO; Hoffmann A; de Oliveira RV; Souza DO; Lara DR
    Psychopharmacology (Berl); 2003 Mar; 166(3):258-63. PubMed ID: 12589526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related differential sensitivity to MK-801-induced locomotion and stereotypy in C57BL/6 mice.
    Qi C; Zou H; Zhang R; Zhao G; Jin M; Yu L
    Eur J Pharmacol; 2008 Feb; 580(1-2):161-8. PubMed ID: 18053981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine and amphetamine sensitization in rats demonstrated under moderate- and high-dose NMDA receptor blockade with MK-801 (dizocilpine).
    Ranaldi R; Munn E; Neklesa T; Wise RA
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):192-201. PubMed ID: 10972465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK-801 in mice.
    Wlaź P; Baran H; Löscher W
    Eur J Pharmacol; 1994 May; 257(3):217-25. PubMed ID: 8088343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.
    Wlaź P
    Brain Res Bull; 1998 Aug; 46(6):535-40. PubMed ID: 9744291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release.
    Homayoun H; Stefani MR; Adams BW; Tamagan GD; Moghaddam B
    Neuropsychopharmacology; 2004 Jul; 29(7):1259-69. PubMed ID: 15010696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-response analysis of the behavioral effects of (+)MK-801 in guinea pig: comparison with CPP.
    Jerram AH; Smith PF; Darlington CL
    Pharmacol Biochem Behav; 1996 Apr; 53(4):799-807. PubMed ID: 8801581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats.
    Abekawa T; Ito K; Nakagawa S; Koyama T
    Psychopharmacology (Berl); 2007 Jun; 192(3):303-16. PubMed ID: 17340116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative anterograde amnestic and anticonvulsant effects of two types of NMDA receptor antagonists: MK-801 and HA-966.
    Xu X; Klinger P; Davis R
    Psychopharmacology (Berl); 1995 Feb; 117(3):333-9. PubMed ID: 7770609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GluN2C/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice.
    Suryavanshi PS; Ugale RR; Yilmazer-Hanke D; Stairs DJ; Dravid SM
    Br J Pharmacol; 2014 Feb; 171(3):799-809. PubMed ID: 24236947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral evidence for modulation by sigma ligands of (+)MK-801-induced hyperlocomotion in monoamine-depleted mice.
    Okuyama S; Imagawa Y; Tomisawa K
    Neuropharmacology; 1996 Apr; 35(4):467-74. PubMed ID: 8793909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociable effects of NR2A and NR2B NMDA receptor antagonism on cognitive flexibility but not pattern separation.
    Kumar G; Olley J; Steckler T; Talpos J
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):3991-4003. PubMed ID: 26184010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of MK-801, a non-competitive NMDA-receptor antagonist, elicits a behavioural deficit of rats in the Active Allothetic Place Avoidance (AAPA) task irrespectively of their intact spatial pretraining.
    Stuchlík A; Vales K
    Behav Brain Res; 2005 Apr; 159(1):163-71. PubMed ID: 15795010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.